Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Century Therapeutics Inc (NASDAQ: IPSC) closed at $0.61 down -1.43% from its previous closing price of $0.61. In other words, the price has decreased by -$1.43 from its previous closing price. On the day, 0.63 million shares were traded.
Ratios:
For a deeper understanding of Century Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.39 and its Current Ratio is at 10.39. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 18 ’25 when Pfeiffenberger Brent sold 34,712 shares for $0.78 per share. The transaction valued at 27,179 led to the insider holds 1,192,545 shares of the business.
Pfeiffenberger Brent bought 34,712 shares of IPSC for $27,166 on Feb 18 ’25. On Feb 03 ’25, another insider, Farid Adrienne, who serves as the Chief Operations Officer of the company, sold 1,054 shares for $0.78 each. As a result, the insider received 822 and left with 134,076 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 19.13 while its Price-to-Book (P/B) ratio in mrq is 0.26.
Stock Price History:
Over the past 52 weeks, IPSC has reached a high of $5.51, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -30.34%, while the 200-Day Moving Average is calculated to be -64.35%.
Shares Statistics:
A total of 84.76M shares are outstanding, with a floating share count of 36.09M. Insiders hold about 57.55% of the company’s shares, while institutions hold 31.62% stake in the company.
